Women's health and night shift work: Potential targets for future strategies in breast cancer (Review)

Briguglio,Giusi; Costa,Chiara; Teodoro,Michele; Giambò,Federica; Italia,Sebastiano; Fenga,Concettina

doi:10.3892/br.2021.1474

Women's health and night shift work: Potential targets for future strategies in breast cancer (Review)

Authors:
- Giusi Briguglio
- Chiara Costa
- Michele Teodoro
- Federica Giambò
- Sebastiano Italia
- Concettina Fenga
View Affiliations

Affiliations: Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Occupational Medicine Section, University of Messina, I‑98125 Messina, Italy, Department of Clinical and Experimental Medicine, University of Messina, I‑98125 Messina, Italy
Published online on: September 24, 2021 https://doi.org/10.3892/br.2021.1474
Article Number: 98
Copyright: © Briguglio et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Breast cancer is the leading cause of cancer‑associated amongst women worldwide. Several studies have shown that individual, environmental and occupational factors can serve an important role in the onset of breast cancer; although the majority of studies have demonstrated this association, and several studies have investigated the biological pathways, it is impossible to describe with certainty the causal relationship that involve circadian rhythm disruption and melatonin dysregulation with the oncogenic processes. Over the years, due to the introduction of more effective screening tools, an increase in the incidence of breast cancer as well as a decrease in the age at diagnosis has been witnessed. Subsequently, an increasing number of individuals have obtained care at a younger age, which has meant that after surgery and chemotherapy, these workers have had to return to work. In light of these paradigmatic changes, the aim of the present review was to identify potential targets for future organisational strategies that should be adopted in the workplace by occupational physicians, both for prevention and for the return‑to‑work process of working women who have suffered from breast cancer.

View Figures

View References

1	World Health Organization International Agency for Research on Cancer (IARC): GLOBOCAN 2020, 2020.
2	Kispert S and McHowat J: Recent insights into cigarette smoking as a lifestyle risk factor for breast cancer. Breast Cancer (Dove Med Press. 9:127–132. 2017.PubMed/NCBI View Article : Google Scholar
3	Costa C, Teodoro M, Rugolo CA, Alibrando C, Giambò F, Briguglio G and Fenga C: MicroRNAs alteration as early biomarkers for cancer and neurodegenerative diseases: New challenges in pesticides exposure. Toxicol Rep. 7:759–767. 2020.PubMed/NCBI View Article : Google Scholar
4	Kumar S, Sharma A and Kshetrimayum C: Environmental and occupational exposure and female reproductive dysfunction. Indian J Med Res. 150:532–545. 2019.PubMed/NCBI View Article : Google Scholar
5	Fenga C: Occupational exposure and risk of breast cancer (Review). Biomed Rep. 4:282–292. 2016.PubMed/NCBI View Article : Google Scholar
6	Golubnitschaja O, Debald M, Yeghiazaryan K, Kuhn W, Pešta M, Costigliola V and Grech G: Breast cancer epidemic in the early twenty-first century: Evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures. Tumor Biol. 37:12941–12957. 2016.PubMed/NCBI View Article : Google Scholar
7	Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L, Ji X, Liu W, Huang B, Luo W, et al: Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 5:77–106. 2018.PubMed/NCBI View Article : Google Scholar
8	Daly AA, Rolph R, Cutress RI and Copson ER: A review of modifiable risk factors in young women for the prevention of breast cancer. Breast Cancer (Dove Med Press). 13:241–257. 2021.PubMed/NCBI View Article : Google Scholar
9	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2017. CA Cancer J Clin. 67:7–30. 2017.PubMed/NCBI View Article : Google Scholar
10	Rudolph A, Chang-Claude J and Schmidt MK: Gene-environment interaction and risk of breast cancer. Br J Cancer. 114:125–133. 2016.PubMed/NCBI View Article : Google Scholar
11	Jung S, Wang M, Anderson K, Baglietto L, Bergkvist L, Bernstein L, van den Brandt PA, Brinton L, Buring JE, Eliassen AH, et al: Alcohol consumption and breast cancer risk by estrogen receptor status: In a pooled analysis of 20 studies. Int J Epidemiol. 45:916–928. 2016.PubMed/NCBI View Article : Google Scholar
12	Ma X, Liu C, Xu X, Liu L, Gao C, Zhuang J, Li H, Feng F, Zhou C, Liu Z, et al: Biomarker expression analysis in different age groups revealed age was a risk factor for breast cancer. J Cell Physiol. 235:4268–4278. 2020.PubMed/NCBI View Article : Google Scholar
13	Yedjou CG, Sims JN, Miele L, Noubissi F, Lowe L, Fonseca DD, Alo RA, Payton M and Tchounwou PB: Health and racial disparity in breast cancer. Adv Exp Med Biol. 1152:31–49. 2019.PubMed/NCBI View Article : Google Scholar
14	Barcenas CH, Wells J, Chong D, French J, Looney SW and Samuel TA: Race as an independent risk factor for breast cancer survival: Breast cancer outcomes from the medical college of Georgia tumor registry. Clin Breast Cancer. 10:59–63. 2010.PubMed/NCBI View Article : Google Scholar
15	Wieder R, Shafiq B and Adam N: African American race is an independent risk factor in survival from initially diagnosed localized breast cancer. J Cancer. 7:1587–1598. 2016.PubMed/NCBI View Article : Google Scholar
16	Taheri M, Tavakol M, Akbari ME, Anoshirvani AA, Aghabozorgi R, Almasi-Hashiani A and Abbasi M: Socioeconomic inequalities in metastasis, recurrence, stage and grade of breast cancer: A hospital-based retrospective cohort study. J Prev Med Hyg. 60:E262–E269. 2019.PubMed/NCBI View Article : Google Scholar
17	Beral V, Bull D, Doll R, Peto R and Reeves G: Breast cancer and breastfeeding: Collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease. Lancet. 360:187–195. 2002.PubMed/NCBI View Article : Google Scholar
18	Johansson H, Bonanni B, Gandini S, Guerrieri-Gonzaga A, Cazzaniga M, Serrano D, Macis D, Puccio A, Sandri MT, Gulisano M, et al: Circulating hormones and breast cancer risk in premenopausal women: A randomized trial of low-dose tamoxifen and fenretinide. Breast Cancer Res Treat. 142:569–578. 2013.PubMed/NCBI View Article : Google Scholar
19	Dall GV and Britt KL: Estrogen effects on the mammary gland in early and late life and breast cancer risk. Front Oncol. 7(110)2017.PubMed/NCBI View Article : Google Scholar
20	Kröz M, Reif M, Glinz A, Berger B, Nikolaou A, Zerm R, Brinkhaus B, Girke M, Büssing A and Gutenbrunner C: CRF-2 study group. Impact of a combined multimodal-aerobic and multimodal intervention compared to standard aerobic treatment in breast cancer survivors with chronic cancer-related fatigue-results of a three-armed pragmatic trial in a comprehensive cohort design. BMC Cancer. 17(166)2017.PubMed/NCBI View Article : Google Scholar
21	Tsaras K, Papathanasiou IV, Mitsi D, Veneti A, Kelesi M, Zyga S and Fradelos EC: Assessment of depression and anxiety in breast cancer patients: Prevalence and associated factors. Asian Pacific J Cancer Prev. 19:1661–1669. 2018.PubMed/NCBI View Article : Google Scholar
22	Fox RS, Ancoli-Israel S, Roesch SC, Merz EL, Mills SD, Wells KJ, Sadler GR and Malcarne VL: Sleep disturbance and cancer-related fatigue symptom cluster in breast cancer patients undergoing chemotherapy. Support Care Cancer. 28:845–855. 2020.PubMed/NCBI View Article : Google Scholar
23	Costa C, Briguglio G, Giambò F, Catanoso R, Teodoro M, Caccamo D and Fenga C: Association between oxidative stress biomarkers and PON and GST polymorphisms as a predictor for susceptibility to the effects of pesticides. Int J Mol Med. 45:1951–1959. 2020.PubMed/NCBI View Article : Google Scholar
24	Costa C, Briguglio G, Catanoso R, Giambò F, Polito I, Teodoro M and Fenga C: New perspectives on cytokine pathways modulation by pesticide exposure. Curr Opin Toxicol. 19:99–104. 2020.
25	Giambò F, Teodoro M, Costa C and Fenga C: Toxicology and microbiota: How do pesticides influence gut microbiota? A review. Int J Environ Res Public Health. 18(5510)2021.PubMed/NCBI View Article : Google Scholar
26	Giambò F, Italia S, Teodoro M, Briguglio G, Furnari N, Catanoso R, Costa C and Fenga C: Influence of toxic metal exposure on the gut microbiota (Review). World Acad Sci J. 3(19)2021.
27	Cohn BA, Cirillo PM and Terry MB: DDT and breast cancer: Prospective study of induction time and susceptibility windows. J Natl Cancer Inst. 111:803–810. 2019.PubMed/NCBI View Article : Google Scholar
28	Darbre PD: Aluminium and the human breast. Morphologie. 100:65–74. 2016.PubMed/NCBI View Article : Google Scholar
29	Filippini T, Torres D, Lopes C, Carvalho C, Moreira P, Naska A, Kasdagli MI, Malavolti M, Orsini N and Vinceti M: Cadmium exposure and risk of breast cancer: A dose-response meta-analysis of cohort studies. Environ Int. 142(105879)2020.PubMed/NCBI View Article : Google Scholar
30	Hiatt RA and Brody JG: Environmental determinants of breast cancer. Annu Rev Public Health. 39:113–133. 2018.PubMed/NCBI View Article : Google Scholar
31	Koual M, Tomkiewicz C, Cano-Sancho G, Antignac JP, Bats AS and Coumoul X: Environmental chemicals, breast cancer progression and drug resistance. Environ Health. 19(117)2020.PubMed/NCBI View Article : Google Scholar
32	Pullella K and Kotsopoulos J: Arsenic exposure and breast cancer risk: A re-evaluation of the literature. Nutrients. 12(3305)2020.PubMed/NCBI View Article : Google Scholar
33	Yang KJ, Lee J and Park HL: Organophosphate pesticide exposure and breast cancer risk: A rapid review of human, animal, and cell-based studies. Int J Environ Res Public Health. 17(5030)2020.PubMed/NCBI View Article : Google Scholar
34	Costa C, Miozzi E, Teodoro M and Fenga C: Influence of genetic polymorphism on pesticide-induced oxidative stress. Curr Opin Toxicol. 13:1–7. 2019.
35	Wegrzyn LR, Tamimi RM, Rosner BA, Brown SB, Stevens RG, Eliassen AH, Laden F, Willett WC, Hankinson SE and Schernhammer ES: Rotating night-shift work and the risk of breast Cancer in the nurses' health studies. Am J Epidemiol. 186:532–540. 2017.PubMed/NCBI View Article : Google Scholar
36	Fagundo-Rivera J, Gómez-Salgado J, García-Iglesias JJ, Gómez-Salgado C, Camacho-Martín S and Ruiz-Frutos C: Relationship between night shifts and risk of breast cancer among nurses: A systematic review. Medicina (Kaunas). 56(680)2020.PubMed/NCBI View Article : Google Scholar
37	Videnros C, Selander J, Wiebert P, Albin M, Plato N, Borgquist S, Manjer J and Gustavsson P: Postmenopausal breast cancer and occupational exposure to chemicals. Scand J Work Environ Heal. 45:642–650. 2019.PubMed/NCBI View Article : Google Scholar
38	Gehlert S and Clanton M: Shift work and breast cancer. Int J Environ Res Public Health. 17(9544)2020.PubMed/NCBI View Article : Google Scholar
39	Lee DG, Burstyn I, Lai AS, Grundy A, Friesen MC, Aronson KJ and Spinelli JJ: Women's occupational exposure to polycyclic aromatic hydrocarbons and risk of breast cancer. Occup Environ Med. 76:22–29. 2019.PubMed/NCBI View Article : Google Scholar
40	Schubauer-Berigan MK, Anderson JL, Hein MJ, Little MP, Sigurdson AJ and Pinkerton LE: Breast cancer incidence in a cohort of U.S. flight attendants. Am J Ind Med. 58:252–266. 2015.PubMed/NCBI View Article : Google Scholar
41	Costa C, Mondello S, Micali E, Indelicato G, Licciardello AA, Vitale E, Briguglio G, Teodoro M and Fenga C: Night shift work in resident physicians: Does it affect mood states and cognitive levels? J Affect Disord. 272:289–294. 2020.PubMed/NCBI View Article : Google Scholar
42	Briguglio G, Teodoro M, Italia S, Verduci F, Pollicino M, Coco M, De Vita A, Micali E, Alibrandi A, Lembo G, et al: Salivary biomarkers and work-related stress in night shift workers. Int J Environ Res Public Health. 18(3184)2021.PubMed/NCBI View Article : Google Scholar
43	Jalilian H, Ziaei M, Weiderpass E, Rueegg CS, Khosravi Y and Kjaerheim K: Cancer incidence and mortality among firefighters. Int J Cancer. 145:2639–2646. 2019.PubMed/NCBI View Article : Google Scholar
44	Labrèche F, Kim J, Song C, Pahwa M, Ge CB, Arrandale VH, McLeod CB, Peters CE, Lavoué J, Davies HW, et al: The current burden of cancer attributable to occupational exposures in Canada. Prev Med. 122:128–139. 2019.PubMed/NCBI View Article : Google Scholar
45	Eurofond. European Working Conditions Survey, 3 Nov, 2020.
46	Szkiela M, Kusideł E, Makowiec-Dabrowska T and Kaleta D: Night shift work-A risk factor for breast cancer. Int J Environ Res Public Health. 17(659)2020.PubMed/NCBI View Article : Google Scholar
47	Gómez-Salgado J, Fagundo-Rivera J, Ortega-Moreno M, Allande-Cussó R, Ayuso-Murillo D and Ruiz-Frutos C: Night work and breast cancer risk in nurses: Multifactorial risk analysis. Cancers (Basel). 13(1470)2021.PubMed/NCBI View Article : Google Scholar
48	IARC: IARC monographs on the evaluation of carcinogenic risks to humans. In: Vol. 93. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, pp9-38, 2010.
49	Bustamante-Montes LP, Flores-Meza B, Hernández-Valero MA, Cárdenas-López A, Dolores-Velázquez R, Borja-Bustamante P and Borja-Aburto VH: Night shift work and risk of breast cancer in women. Arch Med Res. 50:393–399. 2019.PubMed/NCBI View Article : Google Scholar
50	Pahwa M, Labrèche F and Demers PA: Night shift work and breast cancer risk: What do the meta-analyses tell us? Scand J Work Environ Heal. 44:432–435. 2018.PubMed/NCBI View Article : Google Scholar
51	Xiang S, Dauchy RT, Hoffman AE, Pointer D, Frasch T, Blask DE and Hill SM: Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer. J Pineal Res. 67(e12586)2019.PubMed/NCBI View Article : Google Scholar
52	Erdem JS, Notø HØ, Skare Ø, Lie JS, Petersen-Øverleir M, Reszka E, Pepłońska B and Zienolddiny S: Mechanisms of breast cancer risk in shift workers: Association of telomere shortening with the duration and intensity of night work. Cancer Med. 6:1988–1997. 2017.PubMed/NCBI View Article : Google Scholar
53	Erdem JS, Skare Ø, Petersen-Øverleir M, Notø HØ, Lie JS, Reszka E, Pepłońska B and Zienolddiny S: Mechanisms of breast cancer in shift workers: DNA methylation in five core circadian genes in nurses working night shifts. J Cancer. 8:2876–2884. 2017.PubMed/NCBI View Article : Google Scholar
54	Cos S, Álvarez-García V, González A, Alonso CG and Martínez CC: Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer. Oncol Lett. 8:487–492. 2014.PubMed/NCBI View Article : Google Scholar
55	Touitou Y, Reinberg A and Touitou D: Association between light at night, melatonin secretion, sleep deprivation, and the internal clock: Health impacts and mechanisms of circadian disruption. Life Sci. 173:94–106. 2017.PubMed/NCBI View Article : Google Scholar
56	Stevens RG and Schernhammer E: Epidemiology of uriniary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev. 14(551)2005.PubMed/NCBI View Article : Google Scholar
57	El-Benhawy SA, El-Tahan RA and Nakhla SF: Exposure to radiation during work shifts and working at night act as occupational stressors alter redox and inflammatory markers. Arch Med Res. 52:76–83. 2021.PubMed/NCBI View Article : Google Scholar
58	Rosa D, Terzoni S, Dellafiore F and Destrebecq A: Systematic review of shift work and nurses' health. Occup Med (Lond). 69:237–243. 2019.PubMed/NCBI View Article : Google Scholar
59	Cordina-Duverger E, Menegaux F, Popa A, Rabstein S, Harth V, Pesch B, Brüning T, Fritschi L, Glass DC, Heyworth JS, et al: Night shift work and breast cancer: A pooled analysis of population-based case-control studies with complete work history. Eur J Epidemiol. 33:369–379. 2018.PubMed/NCBI View Article : Google Scholar
60	Sweeney MR, Sandler DP, Niehoff NM and White AJ: Shift work and working at night in relation to breast cancer incidence. Cancer Epidemiol Biomarkers Prev. 29:687–689. 2020.PubMed/NCBI View Article : Google Scholar
61	Pahwa M, Labrèche F, Kim J, Harris MA, Song C, Peters CE, Arrandale VH, Davies H, McLeod CB and Demers PA: The impact of night shift work on breast cancer: Results from the burden of occupational cancer in Canada study. Am J Ind Med. 62:635–642. 2019.PubMed/NCBI View Article : Google Scholar
62	Pham TT, Hwang M, Lee ES, Kong SY, Jung SY, Lee S, Kim J, Ha M, Kim SY and Park B: Night-shift work and risk of breast cancer in Korean women. Clin Epidemiol. 11:743–751. 2019.PubMed/NCBI View Article : Google Scholar
63	Jones ME, Schoemaker MJ, McFadden EC, Wright LB, Johns LE and Swerdlow AJ: Night shift work and risk of breast cancer in women: The Generations Study cohort. Br J Cancer. 121:172–179. 2019.PubMed/NCBI View Article : Google Scholar
64	Ritonja J, McIsaac MA, Sanders E, Kyba CCM, Grundy A, Cordina-Duverger E, Spinelli JJ and Aronson KJ: Outdoor light at night at residences and breast cancer risk in Canada. Eur J Epidemiol. 35:579–589. 2020.PubMed/NCBI View Article : Google Scholar
65	Yang W, Shi Y, Ke X, Sun H, Guo J and Wang X: Long-term sleep habits and the risk of breast cancer among Chinese women: A case-control study. Eur J Cancer Prev. 28:323–329. 2019.PubMed/NCBI View Article : Google Scholar
66	Garcia-Saenz A, Sánchez de Miguel A, Espinosa A, Valentin A, Aragonés N, Llorca J, Amiano P, Martín Sánchez V, Guevara M, Capelo R, et al: Evaluating the association between artificial light-at-night exposure and breast and prostate cancer risk in Spain (MCC-Spain study). Environ Health Perspect. 126(047011)2018.PubMed/NCBI View Article : Google Scholar
67	Lacerda JZ, Ferreira LC, Lopes BC, Aristizábal-Pachón AF, Bajgelman MC, Borin TF and de Campos Zuccari DAP: Therapeutic potential of melatonin in the regulation of MiR-148a-3p and angiogenic factors in breast Cancer. Microrna. 8:237–247. 2019.PubMed/NCBI View Article : Google Scholar
68	Rajabi A, Saber A, Pourmahdi M, Emami A, Ravanbakhsh R, Khodavirdipour A, Khodaei M, Akbarzadeh M, Abdolahi S, Hosseinpourfeizi MA and Safaralizadeh R: Anti-cancer effect of melatonin via downregulation of Delta-like ligand 4 in Estrogen-responsive breast cancer cells. Recent Pat Anticancer Drug Discov. 15:329–340. 2020.PubMed/NCBI View Article : Google Scholar
69	El-Sokkary GH, Ismail IA and Saber SH: Melatonin inhibits breast cancer cell invasion through modulating DJ-1/KLF17/ID-1 signaling pathway. J Cell Biochem. 120:3945–3957. 2019.PubMed/NCBI View Article : Google Scholar
70	Liu P and Xie X, Yang A, Kong Y, Allen-Gipson D, Tian Z, Zhou L, Tang H and Xie X: Melatonin regulates breast cancer progression by the lnc010561/miR-30/FKBP3 Axis. Mol Ther Nucleic Acids. 19:765–774. 2020.PubMed/NCBI View Article : Google Scholar
71	Chuffa LGA, Carvalho RF, Justulin LA, Cury SS, Seiva FRF, Jardim-Perassi BV, Zuccari DAPC and Reiter RJ: A meta-analysis of microRNA networks regulated by melatonin in cancer: Portrait of potential candidates for breast cancer treatment. J Pineal Res. 69(e12693)2020.PubMed/NCBI View Article : Google Scholar
72	Salamanca-Fernández E, Rodríguez-Barranco M, Guevara M, Ardanaz E, Olry de Labry Lima A and Sánchez MJ: Night-shift work and breast and prostate cancer risk: Updating the evidence from epidemiological studies. An Sist Sanit Navar. 41:211–226. 2018.PubMed/NCBI View Article : Google Scholar
73	Dun A, Zhao X, Jin X, Wei T, Gao X, Wang Y and Hou H: Association between night-shift work and cancer risk: Updated systematic review and meta-analysis. Front Oncol. 10(1006)2020.PubMed/NCBI View Article : Google Scholar
74	Yuan X, Zhu C, Wang M, Mo F, Du W and Ma X: Night shift work increases the risks of multiple primary cancers in women: A systematic review and meta-analysis of 61 articles. Cancer Epidemiol Biomarkers Prev. 27:25–40. 2018.PubMed/NCBI View Article : Google Scholar
75	Lee HE, Lee J, Jang TW, Kim IA, Park J and Song J: The relationship between night work and breast cancer. Ann Occup Environ Med. 30(11)2018.PubMed/NCBI View Article : Google Scholar
76	Zhou L, Chen X, Liu T, Gong Y, Chen S, Pan G, Cui W, Luo ZP, Pei M, Yang H and He F: Melatonin reverses H2O2-induced premature senescence in mesenchymal stem cells via the SIRT1-dependent pathway. J Pineal Res. 59:190–205. 2015.PubMed/NCBI View Article : Google Scholar
77	de Castro TB, Bordin-Junior NA, de Almeida EA and de Campos Zuccari DAP: Evaluation of melatonin and AFMK levels in women with breast cancer. Endocrine. 62:242–249. 2018.PubMed/NCBI View Article : Google Scholar
78	Samavat H and Kurzer MS: Estrogen metabolism and breast cancer. Cancer Lett. 356:231–243. 2015.PubMed/NCBI View Article : Google Scholar
79	Costa G, Haus E and Stevens R: Shift work and cancer-Considerations on rationale, mechanisms, and epidemiology. Scand J Work Environ Heal. 36:163–179. 2010.PubMed/NCBI View Article : Google Scholar
80	Everson CA, Henchen CJ, Szabo A and Hogg N: Cell injury and repair resulting from sleep loss and sleep recovery in laboratory rats. Sleep. 37:1929–1940. 2014.PubMed/NCBI View Article : Google Scholar
81	Davies SK, Ang JE, Revell VL, Holmes B, Mann A, Robertson FP, Cui N, Middleton B, Ackermann K, Kayser M, et al: Effect of sleep deprivation on the human metabolome. Proc Natl Acad Sci USA. 111:10761–10766. 2014.PubMed/NCBI View Article : Google Scholar
82	Vaughn CB, Freudenheim JL, Nie J, Sucheston-Campbell L, Wactawski-Wende J, Marian C, Shields PG, Kallakury BV, Trevisan M and Ochs-Balcom HM: Sleep and breast cancer in the western New York exposures and breast cancer (WEB) study. J Clin Sleep Med. 14:81–86. 2018.PubMed/NCBI View Article : Google Scholar
83	McNeil J, Heer E, Willemsen RF, Friedenreich CM and Brenner DR: The effects of shift work and sleep duration on cancer incidence in Alberta's Tomorrow Project cohort. Cancer Epidemiol. 67(101729)2020.PubMed/NCBI View Article : Google Scholar
84	Shostak A: Circadian clock, cell division, and cancer: From molecules to organism. Int J Mol Sci. 18(873)2017.PubMed/NCBI View Article : Google Scholar
85	Hernández-Rosas F, López-Rosas CA and Saavedra-Vélez MV: Disruption of the molecular circadian clock and cancer: An Epigenetic Link. Biochem Genet. 58:189–209. 2020.PubMed/NCBI View Article : Google Scholar
86	Sahar S and Sassone-Corsi P: Circadian clock and breast cancer: A molecular link. Cell Cycle. 6:1329–1331. 2007.PubMed/NCBI View Article : Google Scholar
87	Xia L, Ma S, Zhang Y, Wang T, Zhou M, Wang Z and Zhang J: Daily variation in global and local DNA methylation in mouse livers. PLoS One. 10(e0118101)2015.PubMed/NCBI View Article : Google Scholar
88	Shi F, Chen X, Fu A, Hansen J, Stevens R, Tjonneland A, Vogel UB, Zheng T and Zhu Y: Aberrant DNA methylation of miR-219 promoter in long-term night shiftworkers. Environ Mol Mutagen. 54:406–413. 2013.PubMed/NCBI View Article : Google Scholar
89	Kochan DZ, Ilnytskyy Y, Golubov A, Deibel SH, McDonald RJ and Kovalchuk O: Circadian disruption-induced microRNAome deregulation in rat mammary gland tissues. Oncoscience. 2(428)2015.PubMed/NCBI View Article : Google Scholar
90	Pham TT, Lee ES, Kong SY, Kim J, Kim SY, Joo J, Yoon KA and Park B: Night-shift work, circadian and melatonin pathway related genes and their interaction on breast cancer risk: Evidence from a case-control study in Korean women. Sci Rep. 9(10982)2019.PubMed/NCBI View Article : Google Scholar
91	Carugno M, Maggioni C, Crespi E, Bonzini M, Cuocina S, Dioni L, Tarantini L, Consonni D, Ferrari L and Pesatori AC: Night shift work, DNA methylation and telomere length: An investigation on hospital female nurses. Int J Environ Res Public Health. 16(2292)2019.PubMed/NCBI View Article : Google Scholar
92	Bracci M, Ciarapica V, Zabaleta ME, Tartaglione MF, Pirozzi S, Giuliani L, Piva F, Valentino M, Ledda C, Rapisarda V, et al: BRCA1 and BRCA2 gene expression: Diurnal variability and influence of shift work. Cancers (Basel). 11(1146)2019.PubMed/NCBI View Article : Google Scholar
93	Hadadi E, Taylor W, Li XM, Aslan Y, Villote M, Rivière J, Duvallet G, Auriau C, Dulong S, Raymond-Letron I, et al: Chronic circadian disruption modulates breast cancer stemness and immune microenvironment to drive metastasis in mice. Nat Commun. 11(3193)2020.PubMed/NCBI View Article : Google Scholar
94	Montagnese C, Porciello G, Vitale S, Palumbo E, Crispo A, Grimaldi M, Calabrese I, Pica R, Prete M, Falzone L, et al: Quality of life in women diagnosed with breast cancer after a 12-month treatment of lifestyle modifications. Nutrients. 13(136)2020.PubMed/NCBI View Article : Google Scholar
95	Porciello G, Montagnese C, Crispo A, Grimaldi M, Libra M, Vitale S, Palumbo E, Pica R, Calabrese I, Cubisino S, et al: Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial. PLoS One. 15(e0239803)2020.PubMed/NCBI View Article : Google Scholar
96	Briguglio G, Costa C, Pollicino M, Giambò F, Catania S and Fenga C: Polyphenols in cancer prevention: New insights (Review). Int J Funct Nutr. 1(9)2020.
97	Falzone L, Grimaldi M, Celentano E, Augustin LS and Libra M: Identification of modulated micrornas associated with breast cancer, diet, and physical activity. Cancers (Basel). 12(2555)2020.PubMed/NCBI View Article : Google Scholar
98	Montagnese C, Porciello G, Vitale S, Palumbo E, Crispo A, Grimaldi M, Calabrese I, Pica R, Prete M, Falzone L, et al: Quality of life in women diagnosed with breast cancer after a 12-month treatment of lifestyle modifications. Nutrients. 13(136)2020.PubMed/NCBI View Article : Google Scholar
99	Leensen MC, Groeneveld IF, van der Heide I, Rejda T, van Veldhoven PLJ, Berkel SV, Snoek A, Harten WV, Frings-Dresen MH and de Boer AG: Return to work of cancer patients after a multidisciplinary intervention including occupational counselling and physical exercise in cancer patients: A prospective study in the Netherlands. BMJ Open. 7(e014746)2017.PubMed/NCBI View Article : Google Scholar